Low Seroprevalence of SARS-CoV-2 in Rhode Island Blood Donors Determined using Multiple Serological Assay Formats
Open Access
- 26 July 2020
- preprint content
- other
- Published by Cold Spring Harbor Laboratory
Abstract
Epidemic projections and public health policies addressing Coronavirus disease (COVID)-19 have been implemented without data reporting on the seroconversion of the population since scalable antibody testing has only recently become available. We measured the percentage of severe acute respiratory syndrome- Coronavirus-2 (SARS-CoV-2) seropositive individuals from 2,008 blood donors drawn in the state of Rhode Island (RI). We utilized multiple antibody testing platforms, including lateral flow immunoassays (LFAs), enzyme-linked immunosorbent assays (ELISAs) and high throughput serological assays (HTSAs). We report than an estimated seropositive rate of RI blood donors of approximately 0.6% existed in April-May of 2020. These data imply that seroconversion, and thus infection, is likely not widespread within this population. Daily new case rates peaked in RI in late April 2020. We conclude that IgG LFAs and HTSAs are suitable to conduct seroprevalence assays in random populations. More studies will be needed using validated serological tests to improve the precision and report the kinetic progression of seroprevalence estimates.This publication has 16 references indexed in Scilit:
- Validation and Performance Comparison of Three SARS-CoV-2 Antibody AssaysPublished by Cold Spring Harbor Laboratory ,2020
- Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and ControlFrontiers in Immunology, 2020
- COVID-19 Antibody Seroprevalence in Santa Clara County, CaliforniaPublished by Cold Spring Harbor Laboratory ,2020
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccineCellular & Molecular Immunology, 2020
- Correcting under-reported COVID-19 case numbers: estimating the true scale of the pandemicPublished by Cold Spring Harbor Laboratory ,2020
- The proximal origin of SARS-CoV-2Nature Medicine, 2020
- Early dynamics of transmission and control of COVID-19: a mathematical modelling studyThe Lancet Infectious Diseases, 2020
- A new coronavirus associated with human respiratory disease in ChinaNature, 2020
- Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virusJournal of Clinical Virology, 2009
- B-Cell Responses in Patients Who Have Recovered from Severe Acute Respiratory Syndrome Target a Dominant Site in the S2 Domain of the Surface Spike GlycoproteinJournal of Virology, 2005